"The COVID pandemic has highlighted the need to increase vaccination in Africa"
Signature(s)
Amount (.*)
€ 4,750,000
Sector(s)
Industry
: € 4,750,000
Signature date(s)
8/07/2021 : € 4,750,000
Link to source
Data sheet
Other links
News & Stories
Link to source
Other links
Inside the project
How and Why
Accessible health products and vaccines produced in Africa
Why
- Fewer than 2% of the three billion vaccine doses administered globally have been in Africa
- New manufacturing facilities on the continent are essential, as Africa currently imports 99% of its vaccines
- The COVID-19 pandemic highlighted the need to increase vaccination in Africa
How
- The vaccine production facility at the Institut Pasteur de Dakar plans to produce as many as 25 million doses of an approved COVID-19 vaccine a month by the end of 2022
- Improve investment in Africa’s health sector and boost the production and accessibility of heath products and technologies
- Support technology transfer and the creation of regional vaccine manufacturing hubs in other regions of Africa
Sectors & Countries
Story
A COVID-19 vaccine of its own for Africa
To increase vaccination rates, Africa needs to secure more doses. New manufacturing facilities on the continent are essential, as Africa currently imports 99% of its vaccines. The new vaccine production facility at the Institut Pasteur de Dakar is a key link in a vaccine strategy developed by the African Union and the Africa Centres for Disease Control and Prevention.
“Not only does this reinforce the health system, but also through this particular project it will create jobs, develop capacities in terms of knowhow and workforce, while bringing in new technology,” says Sall.
"It’s very important that we have this solidarity between African countries and European countries because it helps to build up a global ecosystem for global health security."
Related media
Health Solutions: Searching for the magic pills
Vaccines get all the attention, but COVID treatments for people who get sick are just as important to end this pandemic
Health Solutions: Why risky ideas are good in a crisis
To end the pandemic and avoid future problems, we must stop being afraid of risk and start innovating in COVID vaccines and all types of other research
A COVID-19 vaccine of its own for Africa
Europe backs COVID-19 vaccine production in Africa with an investment in Senegal’s Institut Pasteur de Dakar.
What’s the impact of an impact investment?
A study supported by the EU bank examines how an impact investment is contributing to improved maternal health services for Senegalese women
Links
Related projects and stories
EIB Group and EBRD sign agreement on accountability arrangements concerning mutual reliance projects
The EIB-CM and EBRD-IPAM signed an Agreement on Accountability Arrangements concerning the Mutual Reliance Projects.
G7 Development Finance Institutions launch the G7 Infrastructure Investment Council to mobilise private capital at scale
The G7 Development Finance Institutions announced the establishment of the G7 Infrastructure Investment Council, a key initiative to scale infrastructure investments for economic prosperity in emerging markets and developing economies.
EIB Group endorses the EU declaration of principles for a gender-equal society
The European Investment Bank Group has endorsed the declaration of principles for a gender-equal society as part of the EU Roadmap for Women’s Rights. The endorsement was showcased during a high-level ceremony hosted by the European Commission on 16 October 2025 in Brussels, which brought together EU institutions and stakeholders to reaffirm their collective commitment to advancing gender equality.